TEHRAN - Iran is among only 30 countries worldwide with the technology to preserve rare blood types for 10 to 30 years through glycerol-based cryopreservation, and is the only country in the region with this capability, according to the head of the Iran Blood Transfusion Organization (IBTO).
Iran Achieves Rare Blood Preservation Technology, Leading the Region
Iran has developed a glycerol-based cryopreservation technology that allows for the preservation of rare blood types for 10 to 30 years, making it one of only 30 countries globally with this capability and the sole country in the region to do so. This advancement was announced by the head of the Iran Blood Transfusion Organization (IBTO). This technology is significant for Iran's healthcare system and blood donation efforts.
👥 Key Players
📰 What Happened
Iran has developed a new glycerol-based cryopreservation technology that allows for the long-term preservation of rare blood types, positioning it as a leader in this field within the region.
- Iran is one of only 30 countries worldwide with this technology.
- This technology allows for blood preservation for 10 to 30 years.
💡 Why It Matters
📚 Background
Cryopreservation is a critical technology for medical treatments, especially for rare blood types, which are often in short supply.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%